Because human breast cancer cell line models were used to characterize the genome-wide binding patterns of STAT3 in TNBC, we next determined if these genome-wide binding patterns are also seen in primary tissue from TNBC tumors. This evidence concerns the gene STAT3 and breast carcinoma.